Lomida 50/300 mg FC tablets
PDF Leaflet Revision Date: 20 February 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of HIV-1 infection in treatment-nau00efve adults aged 18 and older.
Dosage (summary)
One tablet (50/300 mg) once daily.
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly
Pregnancy & Breastfeeding
Use during pregnancy may increase risk of neural tube defects; avoid breastfeeding to prevent HIV transmission.
Key Drug Interactions
- Dofetilide
- Pilsicainide
- Trimethoprim
Contraindications
- Hypersensitivity to components
- Severe hepatic impairment
- Severe renal impairment (CrCl < 50 mL/min)
Common side effects
- Upper abdominal pain
- Diarrhea
- Vomiting
Counselling Points
- Take with or without food
- Monitor for signs of liver dysfunction
- Regular follow-up for HIV management
Serious warnings
- Hypersensitivity reactions
- Lactic acidosis
- Immune reconstitution inflammatory syndrome (IRIS)
Important Disclaimer
The Lomida 50/300 mg FC tablets professional information leaflet below is the property of Cipla Medpro Manufacturing and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
